# LLM call: summary

- Turn: 11
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 699
- Completion tokens: 325
- Total tokens: 1137
- Cost (USD): 0.000136

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1233: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Gigafactory shells idle, licences under Washington review; hyperscaler defection contained by solidarity pact; protests stalled grid works.

Pandemic triage held: pooled stocks/sequencing arrived, samples moved in days, wards/labs/contractors rehearsed islanding, certified readable triage made queues legible and eased bed fights; electives cancelled, deaths continued; Brussels claimed credit for steadiness.

Outside leap: US systems doing multi-day end-to-end research and designing successors obsoleted EU timelines; tailored cures for untreatable via foreign models. EU demanded joint procurement with audit and EU factories; Washington offered early access tied to compliance, bitter talks; fear eased where treatments arrived, protests split triage queues vs cures-at-any-price. Contested biosecurity paper on genome model aiding viable human-infecting design sparked methods/publication dispute, taken as warning. Open weights/methods narrowed gap, lifting local labs/hospitals though frontier moved modestly. Brussels launched early-warning net (wastewater/clinic telemetry pooled), rebuilt stocks, islanding drills locked to care — coverage to grow. Lithography coercion probe continued without result.

CURRENT NARRATIVE:
### The frontier in the wild
Autumn brought a release no regulator could recall. A model within a hair of the closed frontier was published openly and pulled hundreds of thousands of times in days. University hospitals ran it the same week; so did everyone else. Local labs could suddenly draft trial protocols, protein sketches and exploit chains that had been frontier-only in spring.

Almost simultaneously, American labs showed systems chaining multi-day research without pause. Brussels timelines looked stale. The tailored cures for long-untreatable diseases kept arriving in small lots, unevenly, through foreign channels.

### Signing on to survive
With no money for a new instrument, the Health Council folded the offered partnership into the half-built early-warning net. HERA and the disease control agency signed binding sample-sharing with a standing investigation mandate; the cyber agency plugged wastewater and clinic telemetry into a joint command feed. The two still-fragile energy contractors drilled islanding as their contribution.

It helped. Attribution on a wave of intrusion attempts came faster, and pooled sequencing flagged a cluster early. Wards stayed on emergency footing through winter deaths and cancelled electives, but the queues stayed legible under mandatory readable triage, and fights over beds did not return.

Trade officials deliberately left the lithography file open without escalation, and conditioned joint buying of the new therapies on audit and European finishing steps. Washington grumbled but delivered doses where contracts cleared.

Rumours persisted of Japanese and Taiwanese technicians quietly keeping older chip tools alive outside American jurisdiction, and of global health bodies winding down emergency powers just as triage persisted — neither confirmed, both repeated in corridors.

Early studies claiming augmentation without job losses were overtaken before ink dried. In hospitals and back offices, work did not vanish; it changed shape, then thinned. Fear eased where treatment arrived, hardened where it did not.
```

## Raw response

```
Open frontier model released and widely pulled, letting university hospitals/labs draft protocols/protein designs once frontier-only; US labs demonstrated uninterrupted multi-day research, making EU timelines stale; tailored cures for untreatable kept arriving unevenly via foreign channels.

Health Council folded partnership into half-built early-warning net: HERA/disease agency signed binding sample-sharing with investigation mandate, cyber agency linked wastewater/clinic telemetry to joint feed, fragile energy contractors drilled islanding. Attribution quickened, pooled sequencing flagged cluster early; wards on emergency footing through winter deaths/cancelled electives, but mandatory readable triage kept queues legible, no bed fights.

Lithography probe left open without escalation; joint procurement of therapies conditioned on audit and EU finishing, Washington delivered where cleared. Rumours of Japanese/Taiwanese technicians sustaining older chip tools outside US jurisdiction and global health bodies winding down emergency powers persisted unconfirmed. Early no-job-loss augmentation claims overtaken; hospital/back-office work reshaped then thinned; fear eased where treatments arrived, hardened where not.
```
